Microsatellite instability: a review of what the oncologist should know

[1]  M. Wing,et al.  Detection of Microsatellite Instability Biomarkers via Next-Generation Sequencing. , 2019, Methods in molecular biology.

[2]  Dongpei Li,et al.  The cancer exosomes: Clinical implications, applications and challenges , 2020, International journal of cancer.

[3]  G. Sauter,et al.  High homogeneity of mismatch repair deficiency in advanced prostate cancer , 2019, Virchows Archiv.

[4]  Xiao Zhu,et al.  Transcriptome analysis reveals an important candidate gene involved in both nodal metastasis and prognosis in lung adenocarcinoma , 2019, Cell & Bioscience.

[5]  I. Nagtegaal,et al.  Microsatellite instability screening in colorectal adenomas to detect Lynch syndrome patients? A systematic review and meta-analysis , 2019, European Journal of Human Genetics.

[6]  Jiaqi Tang,et al.  Transcriptional regulation in model organisms: recent progress and clinical implications , 2019, Open Biology.

[7]  Dongpei Li,et al.  Circular RNAs: The star molecules in cancer. , 2019, Molecular aspects of medicine.

[8]  R. Kurzrock,et al.  Relationship between protein biomarkers of chemotherapy response and microsatellite status, tumor mutational burden and PD‐L1 expression in cancer patients , 2019, International journal of cancer.

[9]  Jeffrey E. Lee,et al.  Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma , 2019, Journal of Immunotherapy for Cancer.

[10]  Yoon Young Choi,et al.  Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  Jin-liang Wang,et al.  Anti-PD-1 therapy combined with chemotherapy in patients with advanced biliary tract cancer , 2019, Cancer Immunology, Immunotherapy.

[12]  L. Looi,et al.  Screening for microsatellite instability in colorectal carcinoma: Practical utility of immunohistochemistry and PCR with fragment analysis in a diagnostic histopathology setting. , 2019, The Malaysian journal of pathology.

[13]  Yongmei Huang,et al.  The single-cell sequencing: new developments and medical applications , 2019, Cell & Bioscience.

[14]  Tae Won Kim,et al.  Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial. , 2019, The Lancet. Oncology.

[15]  J. Taube,et al.  Intratumoral Adaptive Immunosuppression and Type 17 Immunity in Mismatch Repair Proficient Colorectal Tumors , 2019, Clinical Cancer Research.

[16]  James M. McFarland,et al.  WRN Helicase is a Synthetic Lethal Target in Microsatellite Unstable Cancers , 2019, Nature.

[17]  David M. Thomas,et al.  Genomic stratification and liquid biopsy in a rare adrenocortical carcinoma (ACC) case, with dual lung metastases , 2019, Cold Spring Harbor molecular case studies.

[18]  W. Frankel,et al.  Microsatellite Instability Occurs in a Subset of Follicular Thyroid Cancers. , 2019, Thyroid : official journal of the American Thyroid Association.

[19]  A. Badr,et al.  Microsatellite instability profiling in Egyptian bladder cancer patients: A pilot study. , 2019, Current problems in cancer.

[20]  Donna Niedzwiecki,et al.  Mutational Analysis of Patients With Colorectal Cancer in CALGB/SWOG 80405 Identifies New Roles of Microsatellite Instability and Tumor Mutational Burden for Patient Outcome. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  Ahmet Zehir,et al.  Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  Yoon Young Choi,et al.  MSI-GC-01: Individual patient data (IPD) meta-analysis of microsatellite instability (MSI) and gastric cancer (GC) from four randomized clinical trials (RCTs). , 2019, Journal of Clinical Oncology.

[23]  Yoon Young Choi,et al.  Microsatellite Instability and Programmed Cell Death-Ligand 1 Expression in Stage II/III Gastric Cancer: Post Hoc Analysis of the CLASSIC Randomized Controlled study. , 2019, Annals of surgery.

[24]  P. Kantoff,et al.  Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade , 2019, JAMA oncology.

[25]  A. Duval,et al.  Association of Primary Resistance to Immune Checkpoint Inhibitors in Metastatic Colorectal Cancer With Misdiagnosis of Microsatellite Instability or Mismatch Repair Deficiency Status , 2019, JAMA oncology.

[26]  A. Kirichenko,et al.  Microsatellite Instability (MSI) as an Independent Predictor of Pathologic Complete Response (PCR) in Locally Advanced Rectal Cancer: A National Cancer Database (NCDB) Analysis. , 2020, Annals of surgery.

[27]  E. Oki,et al.  Recent Incidence Trend of Surgically Resected Esophagogastric Junction Adenocarcinoma and Microsatellite Instability Status in Japanese Patients , 2018, Digestion.

[28]  M. Kloor,et al.  Mismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinoma , 2018, British Journal of Cancer.

[29]  D. Le,et al.  Integrating Immunotherapy Into Colorectal Cancer Care. , 2018, Oncology.

[30]  B. Thapa,et al.  Mismatch Repair Protein Defects and Microsatellite Instability in Malignant Pleural Mesothelioma , 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[31]  H. Samadi kafil,et al.  Evaluation of microsatellite instability in tumor and tumor marginal samples of sporadic colorectal cancer using mononucleotide markers , 2018, EXCLI journal.

[32]  Takayuki Takahashi,et al.  Synchronous endometrial and ovarian cancer in Lynch syndrome with a MSH2 germline mutation: A case report , 2018, Molecular and clinical oncology.

[33]  K. Hata,et al.  Predictors for High Microsatellite Instability in Patients with Colorectal Cancer Fulfilling the Revised Bethesda Guidelines , 2018, AntiCancer Research.

[34]  Joon-Oh Park,et al.  Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer , 2018, Nature Medicine.

[35]  R. Reis,et al.  Advantage of HSP110 (T17) marker inclusion for microsatellite instability (MSI) detection in colorectal cancer patients , 2018, Oncotarget.

[36]  V. Brabec,et al.  Simultaneous delivery of olaparib and carboplatin in PEGylated liposomes imparts this drug combination hypersensitivity and selectivity for breast tumor cells , 2018, Oncotarget.

[37]  Ronald J. Hause,et al.  Accurate Pan-Cancer Molecular Diagnosis of Microsatellite Instability by Single-Molecule Molecular Inversion Probe Capture and High-Throughput Sequencing. , 2018, Clinical chemistry.

[38]  P. Nelson,et al.  Microsatellite instability in prostate cancer by PCR or next-generation sequencing , 2018, Journal of Immunotherapy for Cancer.

[39]  Zachary S. Lorsch,et al.  Correction: Corrigendum: Sex-specific transcriptional signatures in human depression , 2018, Nature Medicine.

[40]  M. Kloor,et al.  Lifestyle factors and risk of sporadic colorectal cancer by microsatellite instability status: a systematic review and meta-analyses , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[41]  A. Clark,et al.  Satellite DNA evolution: old ideas, new approaches. , 2018, Current opinion in genetics & development.

[42]  M. Sawyer,et al.  Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  V. G. Biju,et al.  Assessment of microsatellite instability for screening bladder cancer in high-risk population , 2018, Journal of cancer research and therapeutics.

[44]  R. Soslow,et al.  Molecular insights into the classification of high-grade endometrial carcinoma. , 2017, Pathology.

[45]  First Comprehensive Companion Diagnostic OK'd. , 2018, Cancer discovery.

[46]  D. Tritchler,et al.  An NRG Oncology/GOG study of molecular classification for risk prediction in endometrioid endometrial cancer. , 2018, Gynecologic oncology.

[47]  Nivolumab plus Ipilimumab Achieves Responses in dMMR/MSI-H Tumors. , 2018, Cancer discovery.

[48]  Yingyan Yu Molecular classification and precision therapy of cancer: immune checkpoint inhibitors , 2018, Frontiers of Medicine.

[49]  A. Santoro,et al.  Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma , 2017, PloS one.

[50]  K. Cole,et al.  Comprehensive Analysis of Hypermutation in Human Cancer , 2017, Cell.

[51]  Russell Bonneville,et al.  Landscape of Microsatellite Instability Across 39 Cancer Types. , 2017, JCO precision oncology.

[52]  J. Shendure,et al.  Corrigendum: Classification and characterization of microsatellite instability across 18 cancer types , 2017, Nature Medicine.

[53]  J. Desai,et al.  Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study. , 2017, The Lancet. Oncology.

[54]  M. Garrido-Ramos Satellite DNA: An Evolving Topic , 2017, Genes.

[55]  Ahmet Zehir,et al.  Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testing , 2017, BMC Medical Genomics.

[56]  Levi Garraway,et al.  Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden , 2017, Genome Medicine.

[57]  S. Paik,et al.  Prognosis of stage III colorectal carcinomas with FOLFOX adjuvant chemotherapy can be predicted by molecular subtype , 2017, Oncotarget.

[58]  T. Patel,et al.  Microsatellite Instability in Chronic Myeloid Leukemia using D17S261 and D3S643 markers: A Pilot Study in Gujarat Population. , 2017, Indian journal of cancer.

[59]  C. Bloomfield,et al.  No evidence for microsatellite instability in acute myeloid leukemia , 2017, Leukemia.

[60]  Ahmed Kamel,et al.  Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology. , 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

[61]  M. Rugge,et al.  Mismatch Repair Deficiency, Microsatellite Instability, and Survival: An Exploratory Analysis of the Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) Trial , 2017, JAMA oncology.

[62]  H. Sakamoto,et al.  High concordance rate of KRAS/BRAF mutations and MSI-H between primary colorectal cancer and corresponding metastases. , 2017, Oncology reports.

[63]  Lauren L. Ritterhouse,et al.  Clear cell ovarian cancers with microsatellite instability: A unique subset of ovarian cancers with increased tumor-infiltrating lymphocytes and PD-1/PD-L1 expression , 2017, Oncoimmunology.

[64]  Russell Bonneville,et al.  Performance evaluation for rapid detection of pan-cancer microsatellite instability with MANTIS , 2016, Oncotarget.

[65]  J. Kench,et al.  Hypermutation In Pancreatic Cancer. , 2017, Gastroenterology.

[66]  Ö. Türeci,et al.  Corrigendum: Positively selected enhancer elements endow osteosarcoma cells with metastatic competence , 2017, Nature Medicine.

[67]  P. Park,et al.  A molecular portrait of microsatellite instability across multiple cancers , 2016, Nature Communications.

[68]  L. Diaz,et al.  Preliminary results of a phase II study: PD-1 blockade in mismatch repair–deficient, recurrent or persistent endometrial cancer , 2016 .

[69]  Markovic Srdjan,et al.  Microsatellite instability & survival in patients with stage II/III colorectal carcinoma , 2016, The Indian journal of medical research.

[70]  Yoon Young Choi,et al.  Molecular Dimensions of Gastric Cancer: Translational and Clinical Perspectives , 2015, Journal of pathology and translational medicine.

[71]  F. Roviello,et al.  Strong Prognostic Value of Microsatellite Instability in Intestinal Type Non-cardia Gastric Cancer , 2016, Annals of Surgical Oncology.

[72]  Lauren L. Ritterhouse,et al.  Association of Polymerase e-Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1. , 2015, JAMA oncology.

[73]  R. Monasson,et al.  Distinguishing the immunostimulatory properties of noncoding RNAs expressed in cancer cells , 2015, Proceedings of the National Academy of Sciences.

[74]  Hoguen Kim,et al.  Usefulness of Immunohistochemistry for Microsatellite Instability Screening in Gastric Cancer , 2015, Gut and liver.

[75]  Bert Vogelstein,et al.  PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. , 2015, The New England journal of medicine.

[76]  B. Vogelstein,et al.  PD-1 blockade in tumors with mismatch repair deficiency. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[77]  K. Koike,et al.  PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. , 2015, The New England journal of medicine.

[78]  A. Hartmann,et al.  Low frequency of HNPCC-associated microsatellite instability and aberrant MMR protein expression in early-onset bladder cancer. , 2014, American journal of clinical pathology.

[79]  P. Gibbs,et al.  Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H). , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[80]  A. Evans,et al.  Patients with Lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancer. , 2013, European urology.

[81]  M. Bronner,et al.  A Five-marker Panel in a Multiplex PCR Accurately Detects Microsatellite Instability-high Colorectal Tumors Without Control DNA , 2012, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[82]  G. Tallini,et al.  T[20] repeat in the 3′-untranslated region of the MT1X gene: a marker with high sensitivity and specificity to detect microsatellite instability in colorectal cancer , 2012, International Journal of Colorectal Disease.

[83]  Fred H. Gage,et al.  BRCA1 tumor suppression occurs via heterochromatin mediated silencing , 2011, Nature.

[84]  R. Jover,et al.  EPCAM germ line deletions as causes of Lynch syndrome in Spanish patients. , 2010, The Journal of molecular diagnostics : JMD.

[85]  R. Labianca,et al.  Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[86]  M. Linnebacher,et al.  Identification of an MSI-H Tumor-Specific Cytotoxic T Cell Epitope Generated by the (−1) Frame of U79260(FTO) , 2010, Journal of biomedicine & biotechnology.

[87]  P. Lara,et al.  Microsatellite instability predicts clinical outcome in radiation-treated endometrioid endometrial cancer. , 2010, International journal of radiation oncology, biology, physics.

[88]  P. Hutter,et al.  Selection of patients with germline MLH1 mutated Lynch syndrome by determination of MLH1 methylation and BRAF mutation , 2010, Familial Cancer.

[89]  Minshan Chen,et al.  Single nucleotide polymorphism of rs430397 in the fifth intron of GRP78 gene and clinical relevance of primary hepatocellular carcinoma in Han Chinese: Risk and prognosis , 2009, International journal of cancer.

[90]  Zhenzhu Zheng,et al.  [Microsatellite instability and allele-specific chromosome 3p deletion in breast cancer and precancerous lesions]. , 2007, Zhonghua zhong liu za zhi [Chinese journal of oncology].

[91]  B. Robinson,et al.  5-Fluorouracil (5FU) treatment does not influence invasion and metastasis in microsatellite unstable (MSI-H) colorectal cancer , 2006, International Journal of Colorectal Disease.

[92]  Lawrence J. Burgart,et al.  Development of a Fluorescent Multiplex Assay for Detection of MSI-High Tumors , 2004, Disease markers.

[93]  Fengzhu Sun,et al.  The relationship between microsatellite slippage mutation rate and the number of repeat units. , 2003, Molecular biology and evolution.

[94]  A. Duval,et al.  Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR. , 2002, Gastroenterology.

[95]  E. Ozer,et al.  Microsatellite instability in early-onset breast cancer. , 2002, Pathology, research and practice.

[96]  J. Nesland,et al.  Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[97]  H. Yamamoto,et al.  Adenocarcinomas with Widespread Microsatellite Instability Genetic and Clinical Features of Human Pancreatic Ductal Updated , 2001 .

[98]  M. Choti,et al.  NCCN Practice Guidelines for Colorectal Cancer. , 2000, Oncology.

[99]  M. Choti,et al.  Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: A newly described and characterized entity. , 2000, The American journal of pathology.

[100]  J. Eshleman,et al.  Detection of microsatellite instability by fluorescence multiplex polymerase chain reaction. , 2000, The Journal of molecular diagnostics : JMD.

[101]  S Srivastava,et al.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. , 1998, Cancer research.

[102]  J. Rüschoff,et al.  Aspirin suppresses the mutator phenotype associated with hereditary nonpolyposis colorectal cancer by genetic selection. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[103]  D. Schaid,et al.  Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. , 1998, Cancer research.

[104]  D. Queller,et al.  Detection of highly polymorphic microsatellite loci in a species with little allozyme polymorphism , 1993, Molecular ecology.